These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36036090)

  • 21. Role of ABO blood system in COVID-19: Findings from a southern Italian study.
    Negro P; Congedo M; Zizza A; Guido M; Sacquegna G; Pulito G; Lobreglio G
    Transfus Med; 2022 Jun; 32(3):243-247. PubMed ID: 34114287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
    Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
    Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoimmunity is a hallmark of post-COVID syndrome.
    Rojas M; Rodríguez Y; Acosta-Ampudia Y; Monsalve DM; Zhu C; Li QZ; Ramírez-Santana C; Anaya JM
    J Transl Med; 2022 Mar; 20(1):129. PubMed ID: 35296346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of blood group types on the risk of COVID-19 infection and its clinical outcome.
    Göker H; Aladağ Karakulak E; Demiroğlu H; Ayaz Ceylan ÇM; Büyükaşik Y; Inkaya AÇ; Aksu S; Sayinalp N; Haznedaroğlu IC; Uzun Ö; Akova M; Özcebe OI; Ünal S
    Turk J Med Sci; 2020 Jun; 50(4):679-683. PubMed ID: 32496734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate.
    Kotila TR; Alonge TO; Fowotade A; Famuyiwa OI; Akinbile AS
    Vox Sang; 2021 Sep; 116(8):910-915. PubMed ID: 33529391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 Working Group.
    Goel R; Bloch EM; Pirenne F; Al-Riyami AZ; Crowe E; Dau L; Land K; Townsend M; Jecko T; Rahimi-Levene N; Patidar G; Josephson CD; Arora S; Vermeulen M; Vrielink H; Montemayor C; Oreh A; Hindawi S; van den Berg K; Serrano K; So-Osman C; Wood E; Devine DV; Spitalnik SL;
    Vox Sang; 2021 Sep; 116(8):849-861. PubMed ID: 33578447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abo Blood Group, Atherothrombotic Comorbidities, and COVID-19: A Case-Control Study of their Association in the Mexican Population.
    Gamboa-Aguilar J; Zamorano-Montaño ÁC; Enríquez-Osorio A; Torres-Cubillas W; López-Arroyo JL; Chapol JAM; Zurita-Martínez H; Pascual JR; Saldaña-Campos E; Rojas-Castillejos F; Madera-Maldonado CE; Peñafiel COR; Maldonado EB; Rascón RG; Hernández-Juárez J; Silos-Briones G; Domínguez SM; Pérez-Ramírez ÓJ; Sosa-Camas RE; Romero-López C; Guzmán-Chores L; Amador-Sánchez R; Ledesma-de la Cruz C; Campos-Cabrera G; Ramírez-Chávez LL; Esparza-García JC; Vela-Ojeda J; García-Chávez J; González-Trejo JJ; Rodríguez-Mejorada SM; Rosado-Castro RA; de Arredondo RAS; Pérez-Hernández VH; Majluf-Cruz K; Domínguez-Reyes V; Arreola-Diaz R; Alvarado-Moreno JA; Majluf-Cruz A
    Arch Med Res; 2022 Jan; 53(1):100-108. PubMed ID: 34649737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study.
    Ray JG; Park AL
    BMJ Open; 2022 Jul; 12(7):e059944. PubMed ID: 35851010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome.
    Bertin D; Kaphan E; Weber S; Babacci B; Arcani R; Faucher B; Ménard A; Brodovitch A; Mege JL; Bardin N
    Int J Infect Dis; 2021 Dec; 113():23-25. PubMed ID: 34614444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.
    Franchini M; Cruciani M; Mengoli C; Marano G; Candura F; Lopez N; Pati I; Pupella S; De Angelis V
    Blood Transfus; 2021 Jul; 19(4):317-326. PubMed ID: 34059188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
    Hasan M; Moiz B; Qaiser S; Masood KI; Ghous Z; Hussain A; Ali N; Simas JP; Veldhoen M; Alves P; Abidi SH; Ghias K; Khan E; Hasan Z
    PLoS One; 2022; 17(8):e0271259. PubMed ID: 36001587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of ABO blood group with the asymptomatic COVID-19 cases in India.
    Singh PP; Srivastava AK; Upadhyay SK; Singh A; Upadhyay S; Kumar P; Rai V; Shrivastava P; Chaubey G;
    Transfus Apher Sci; 2021 Dec; 60(6):103224. PubMed ID: 34366234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging.
    Schaefer EJ; Dulipsingh L; Comite F; Jimison J; Grajower MM; Lebowitz NE; Lang M; Geller AS; Diffenderfer MR; He L; Breton G; Dansinger ML; Saida B; Yuan C
    PLoS One; 2021; 16(6):e0252818. PubMed ID: 34111164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.
    Barnkob MB; Pottegård A; Støvring H; Haunstrup TM; Homburg K; Larsen R; Hansen MB; Titlestad K; Aagaard B; Møller BK; Barington T
    Blood Adv; 2020 Oct; 4(20):4990-4993. PubMed ID: 33057631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Course of Humoral and Cellular Immune Responses in Outpatients After SARS-CoV-2 Infection.
    Schiffner J; Backhaus I; Rimmele J; Schulz S; Möhlenkamp T; Klemens JM; Zapf D; Solbach W; Mischnik A
    Front Public Health; 2021; 9():732787. PubMed ID: 34646805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.